| Product Code: ETC406877 | Publication Date: Oct 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The China Animal Model Market was estimated at USD 152 Million in 2025 and is projected to reach USD 175 Million by 2032, growing at a CAGR of 2.0% from 2026 to 2032. This growth is being fueled by an increasing emphasis on drug discovery and the rising prevalence of chronic diseases that demand effective treatment solutions. As research activities intensify, particularly in genetics and biomedical research, the need for sophisticated animal models—especially mice and rats—continues to escalate.
This graph highlights how the China Animal Model Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.5% | decrease in research funding allocations |
| 2022 | 6.3% | increase in biopharmaceutical research investments |
| 2023 | -1.6% | drop in laboratory utilization rates |
| 2024 | 4.2% | expansion of regulatory approvals process |
| 2025 | 3.2% | growth in personalized medicine applications |
| 2026 | 4.0% | rise in academic research collaborations |
| 2027 | 3.1% | enhancement of preclinical testing standards |
| 2028 | 3.0% | development of innovative research techniques |
| 2029 | 2.5% | increased domestic production output |
| 2030 | 2.5% | increased production capacity utilization |
| 2031 | 3.0% | expanding manufacturing base activity |
| 2032 | 2.5% | strengthening of ethical research guidelines |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
While the China Animal Model Market has seen considerable momentum recently, its trajectory is evolving towards specialized solutions that meet the rising demands of pharmaceutical and biotechnology sectors. Researchers are increasingly focused on utilizing genetically engineered animal models that enhance the precision of their studies, reflecting a significant shift in research methodologies.
The market is poised to undergo further transformation as advanced technologies, including CRISPR/Cas9 gene editing, become more widely adopted. These innovations not only offer more precise models for experimentation but also align with the growing trends in precision medicine and personalized treatment strategies.
Despite its robust growth, the China Animal Model Market faces several constraints. Ethical concerns surrounding animal testing are increasingly in the spotlight, resulting in heightened scrutiny from regulatory bodies. Additionally, the costs associated with breeding and maintaining animal models can be significant, potentially hindering smaller research organizations from entering the market. Moreover, competition from alternative methods to animal testing is growing, fueled by advances in technology that offer potentially reliable substitutes. This complex landscape necessitates a strategic approach from market players to ensure both compliance and sustainability.
Key trends influencing the China Animal Model Market include a pronounced shift towards personalized medicine, which necessitates the use of specialized animal models that can mimic human diseases more accurately. The integration of non-invasive imaging technologies in preclinical studies is also contributing to this evolution, allowing researchers to gather data with minimal disruption to the animal subjects. The continuous advancement of genetic engineering technologies, including more refined CRISPR techniques, further supports the need for more sophisticated and customized models, positioning the market for future growth.
The China Animal Model Market presents numerous investment opportunities, particularly within the pharmaceutical and biotechnology sectors. With the escalating demand for preclinical testing and customized animal models, companies specializing in genetically modified animals and associated research services are well-positioned for growth. Additionally, the burgeoning field of precision medicine, along with advancements in gene editing technologies, paves the way for innovative approaches and new avenues for investment. Stakeholders who focus on aligning their offerings with the evolving needs of the research community stand to benefit significantly.
The Chinese government has introduced several regulations aimed at ensuring the ethical treatment of animals used in research. The "Regulation on the Administration of Laboratory Animals" establishes care standards for research animals, while the "Animal Epidemic Prevention Law" focuses on disease control within animal populations. These policies underscore a commitment to humane practices while promoting scientific advancement. Additionally, efforts to align local regulations with international standards are facilitating greater collaboration and knowledge exchange within the global research community.
Looking forward to 2026-2032, the China Animal Model Market is set to expand significantly, driven by the ongoing demand for innovative solutions in drug discovery and biomedical research. With a keen focus on chronic diseases, the market will likely see a surge in the development of specialized animal models that cater to the nuances of individual conditions. The interplay between government initiatives and technological advancements is expected to foster a conducive environment for growth, ensuring that the market evolves in alignment with ethical standards and research needs.
In the recent months leading to mid-2026, the China Animal Model Market has been witnessing a notable shift towards collaborative efforts between research institutions and pharmaceutical firms. Innovations in gene editing technologies are becoming more prevalent, providing researchers with enhanced tools for developing customized animal models. Furthermore, the regulatory landscape is adapting to address emerging ethical concerns while promoting the continued advancement of animal research, reflecting a balanced approach to scientific exploration.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Animal Model Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Animal Model Market Revenues & Volume, 2022 & 2032F |
3.3 China Animal Model Market - Industry Life Cycle |
3.4 China Animal Model Market - Porter's Five Forces |
3.5 China Animal Model Market Revenues & Volume Share, By Animal Type , 2022 & 2032F |
3.6 China Animal Model Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 China Animal Model Market Revenues & Volume Share, By End Users, 2022 & 2032F |
4 China Animal Model Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for preclinical testing in pharmaceutical and biotechnology industries |
4.2.2 Growing prevalence of chronic diseases requiring research and development of new treatments |
4.2.3 Technological advancements leading to the development of more accurate and reliable animal models |
4.3 Market Restraints |
4.3.1 Ethical concerns and regulatory restrictions surrounding the use of animals in research |
4.3.2 High costs associated with breeding, housing, and maintaining animal models |
4.3.3 Availability of alternative research methods such as in vitro and in silico models |
5 China Animal Model Market Trends |
6 China Animal Model Market, By Types |
6.1 China Animal Model Market, By Animal Type |
6.1.1 Overview and Analysis |
6.1.2 China Animal Model Market Revenues & Volume, By Animal Type , 2022-2032F |
6.1.3 China Animal Model Market Revenues & Volume, By Rat, 2022-2032F |
6.1.4 China Animal Model Market Revenues & Volume, By Mice, 2022-2032F |
6.1.5 China Animal Model Market Revenues & Volume, By Guinea Pigs, 2022-2032F |
6.1.6 China Animal Model Market Revenues & Volume, By Rabbits, 2022-2032F |
6.1.7 China Animal Model Market Revenues & Volume, By Others, 2022-2032F |
6.2 China Animal Model Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Animal Model Market Revenues & Volume, By Drug Discovery & Development, 2022-2032F |
6.2.3 China Animal Model Market Revenues & Volume, By Basic Research, 2022-2032F |
6.2.4 China Animal Model Market Revenues & Volume, By Others, 2022-2032F |
6.3 China Animal Model Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 China Animal Model Market Revenues & Volume, By Pharma & Biotech Companies, 2022-2032F |
6.3.3 China Animal Model Market Revenues & Volume, By Academic Research Institutes, 2022-2032F |
6.3.4 China Animal Model Market Revenues & Volume, By Others, 2022-2032F |
7 China Animal Model Market Import-Export Trade Statistics |
7.1 China Animal Model Market Export to Major Countries |
7.2 China Animal Model Market Imports from Major Countries |
8 China Animal Model Market Key Performance Indicators |
8.1 Average lifespan of animal models used in research |
8.2 Adoption rate of genetically modified animal models |
8.3 Number of research publications utilizing animal models in China |
9 China Animal Model Market - Opportunity Assessment |
9.1 China Animal Model Market Opportunity Assessment, By Animal Type , 2022 & 2032F |
9.2 China Animal Model Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 China Animal Model Market Opportunity Assessment, By End Users, 2022 & 2032F |
10 China Animal Model Market - Competitive Landscape |
10.1 China Animal Model Market Revenue Share, By Companies, 2025 |
10.2 China Animal Model Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here